
Paul V. Ward
Examiner (ID: 4583)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624, 1622, 1623 |
| Total Applications | 2519 |
| Issued Applications | 1801 |
| Pending Applications | 239 |
| Abandoned Applications | 539 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18181383
[patent_doc_number] => 20230042112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => A Process For Preparing Isoindolinone Derivative, Novel Intermediates Used For The Process, And A Process For Preparing The Intermediates
[patent_app_type] => utility
[patent_app_number] => 17/782500
[patent_app_country] => US
[patent_app_date] => 2020-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3178
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782500
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/782500 | A Process For Preparing Isoindolinone Derivative, Novel Intermediates Used For The Process, And A Process For Preparing The Intermediates | Dec 2, 2020 | Pending |
Array
(
[id] => 18107882
[patent_doc_number] => 20230000762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => INJECTABLE HYDROGELS FOR CELL DELIVERY TO THE VITREOUS
[patent_app_type] => utility
[patent_app_number] => 17/781076
[patent_app_country] => US
[patent_app_date] => 2020-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23778
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781076
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781076 | Injectable hydrogels for cell delivery to the vitreous | Dec 2, 2020 | Issued |
Array
(
[id] => 18272525
[patent_doc_number] => 20230093767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => COMPOSITION CONTAINING 4-(3-ETHOXY-4-HYDROXYPHENYL)BUTAN-2-ONE, A PRESERVATIVE AND/OR ANTIOXIDANT, A SURFACTANT AND A POLYMER, AND THE METHOD FOR PROCESSING KERATIN MATERIALS FROM THE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/781428
[patent_app_country] => US
[patent_app_date] => 2020-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22492
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781428
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781428 | COMPOSITION CONTAINING 4-(3-ETHOXY-4-HYDROXYPHENYL)BUTAN-2-ONE, A PRESERVATIVE AND/OR ANTIOXIDANT, A SURFACTANT AND A POLYMER, AND THE METHOD FOR PROCESSING KERATIN MATERIALS FROM THE COMPOSITION | Dec 1, 2020 | Pending |
Array
(
[id] => 18222089
[patent_doc_number] => 20230061083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => KRAS G12C INHIBITOR COMPOUND AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/779684
[patent_app_country] => US
[patent_app_date] => 2020-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17779684
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/779684 | KRAS G12C INHIBITOR COMPOUND AND USE THEREOF | Nov 26, 2020 | Abandoned |
Array
(
[id] => 16976127
[patent_doc_number] => 20210220364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => COMBINATION THERAPY INVOLVING DIARYL MACROCYCLIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/104752
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30979
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104752
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/104752 | Combination therapy involving diaryl macrocyclic compounds | Nov 24, 2020 | Issued |
Array
(
[id] => 16711807
[patent_doc_number] => 20210078954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => GUANIDYL-CONTAINING P2Y12 RECEPTOR ANTAGONIST AND PREPARATION METHOD AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/105445
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7660
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 484
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17105445
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/105445 | Guanidyl-containing P2Y12 receptor antagonist and preparation method and application thereof | Nov 24, 2020 | Issued |
Array
(
[id] => 18399298
[patent_doc_number] => 11661424
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-30
[patent_title] => Process for preparing BTK inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/102086
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 34518
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102086
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/102086 | Process for preparing BTK inhibitors | Nov 22, 2020 | Issued |
Array
(
[id] => 18216392
[patent_doc_number] => 11591314
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Process for preparing tetrahydrocarbazole carboxamide compound
[patent_app_type] => utility
[patent_app_number] => 17/101411
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17983
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17101411
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/101411 | Process for preparing tetrahydrocarbazole carboxamide compound | Nov 22, 2020 | Issued |
Array
(
[id] => 18056583
[patent_doc_number] => 20220387669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => CONTROLLED-VISCOSITY POLYMERIC HYDROGEL AND METHOD FOR MAKING IT
[patent_app_type] => utility
[patent_app_number] => 17/775779
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17775779
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/775779 | CONTROLLED-VISCOSITY POLYMERIC HYDROGEL AND METHOD FOR MAKING IT | Nov 18, 2020 | Pending |
Array
(
[id] => 16807777
[patent_doc_number] => 20210130330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => SOLID FORMS OF CERDULATINIB
[patent_app_type] => utility
[patent_app_number] => 17/098852
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098852 | Solid forms of Cerdulatinib | Nov 15, 2020 | Issued |
Array
(
[id] => 16807777
[patent_doc_number] => 20210130330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => SOLID FORMS OF CERDULATINIB
[patent_app_type] => utility
[patent_app_number] => 17/098852
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098852 | Solid forms of Cerdulatinib | Nov 15, 2020 | Issued |
Array
(
[id] => 16807777
[patent_doc_number] => 20210130330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => SOLID FORMS OF CERDULATINIB
[patent_app_type] => utility
[patent_app_number] => 17/098852
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098852 | Solid forms of Cerdulatinib | Nov 15, 2020 | Issued |
Array
(
[id] => 16807777
[patent_doc_number] => 20210130330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => SOLID FORMS OF CERDULATINIB
[patent_app_type] => utility
[patent_app_number] => 17/098852
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098852 | Solid forms of Cerdulatinib | Nov 15, 2020 | Issued |
Array
(
[id] => 18887665
[patent_doc_number] => 11866426
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Benzothiazole compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/098880
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31173
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 3969
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098880
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098880 | Benzothiazole compounds and uses thereof | Nov 15, 2020 | Issued |
Array
(
[id] => 18075776
[patent_doc_number] => 20220401388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => METHODS FOR USING LOW-DOSE COLCHICINE AFTER MYOCARDIAL INFARCTION
[patent_app_type] => utility
[patent_app_number] => 17/776690
[patent_app_country] => US
[patent_app_date] => 2020-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776690
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776690 | METHODS FOR USING LOW-DOSE COLCHICINE AFTER MYOCARDIAL INFARCTION | Nov 12, 2020 | Pending |
Array
(
[id] => 18590191
[patent_doc_number] => 11739071
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/096349
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26071
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1243
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17096349
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/096349 | Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors | Nov 11, 2020 | Issued |
Array
(
[id] => 16868430
[patent_doc_number] => 20210161897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/094893
[patent_app_country] => US
[patent_app_date] => 2020-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7356
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17094893
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/094893 | EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER | Nov 10, 2020 | Abandoned |
Array
(
[id] => 16688286
[patent_doc_number] => 20210070762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => SYNTHESIS OF COELENTERAZINE
[patent_app_type] => utility
[patent_app_number] => 17/089573
[patent_app_country] => US
[patent_app_date] => 2020-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17089573
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/089573 | Synthesis of coelenterazine | Nov 3, 2020 | Issued |
Array
(
[id] => 16839920
[patent_doc_number] => 20210147932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => FLUORESCENT PROBES FOR QUANTIFICATION OF DNA DAMAGE AND REPAIR
[patent_app_type] => utility
[patent_app_number] => 17/088119
[patent_app_country] => US
[patent_app_date] => 2020-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26951
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17088119
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/088119 | FLUORESCENT PROBES FOR QUANTIFICATION OF DNA DAMAGE AND REPAIR | Nov 2, 2020 | Abandoned |
Array
(
[id] => 17385525
[patent_doc_number] => 20220033377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => Chemical Process for the Synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline
[patent_app_type] => utility
[patent_app_number] => 17/086666
[patent_app_country] => US
[patent_app_date] => 2020-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17086666
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/086666 | Chemical Process for the Synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline | Nov 1, 2020 | Abandoned |